WEBINAR | The IPI Model: Breaking Down CMS’s Proposed Drug Pricing Model

November 08, 2018

McDermott+Consulting

This program previously aired live on November 19, 2018.

You can view an on-demand recording here. Please note you will be asked to register.

The program slides are available here.

* * * * *

Join McDermott+Consulting and McDermott Will & Emery for a complimentary webinar on changes to the pharma ecosystem.

The Centers for Medicare and Medicaid Services (CMS)’s October 25 announcement of an Advanced Notice of Proposed Rulemaking with Comment proposes to implement an international pricing index model for Medicare Part B drugs and biologicals.  This model has the potential to make sweeping changes to the entire pharmaceutical ecosystem.

Join McDermott Will & Emery’s Emily Cook and McDermott+Consulting’s John Warren as they lead a discussion on the impact of CMS’s proposed model and break down the implications on stakeholder groups from providers to drug manufacturers.

  • Date: November 19, 2018
  • Time: 1:00 – 2:00 pm  EST

Click here to register.

Speakers:

 


For questions or additional information please contact Jenny Randles at jrandles@mcdermottplus.com or +1 202 204 1461.

Previous Post / Next Post
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope